Journal Mobile Options
Table of Contents
Vol. 25, No. 3, 2008
Issue release date: March 2008
Cerebrovasc Dis 2008;25:282–283
(DOI:10.1159/000119638)

Brain Haemorrhage and Cerebral Vasospasm Associated with Chronic Use of Cannabis and Buprenorphine

Renard D. · Gaillard N.
Department of Neurology, CHU Montpellier, Hôpital Gui de Chauliac, Montpellier, France
email Corresponding Author


 Outline


 goto top of outline Abstract

Sorry, there is no abstract.

Copyright © 2006 S. Karger AG, Basel


 goto top of outline Author Contacts

Dimitri Renard, MD
Department of Neurology, CHU Montpellier
Hôpital Gui de Chauliac
80 Avenue Augustin Fliche
FR–34295 Montpellier (France)
Tel. +33 46 733 7353, Fax +33 46 733 7980
E-Mail dimitrirenard@hotmail.com


 goto top of outline Article Information

Published online: March 7, 2008
Number of Print Pages : 2


 goto top of outline Publication Details

Cerebrovascular Diseases

Vol. 25, No. 3, Year 2008 (Cover Date: March 2008)

Journal Editor: Hennerici M.G. (Mannheim)
ISSN: 1015–9770 (Print), eISSN: 1421–9786 (Online)

For additional information: http://www.karger.com/CED


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

First-Page Preview
Abstract of Stroke Notes

 goto top of outline Author Contacts

Dimitri Renard, MD
Department of Neurology, CHU Montpellier
Hôpital Gui de Chauliac
80 Avenue Augustin Fliche
FR–34295 Montpellier (France)
Tel. +33 46 733 7353, Fax +33 46 733 7980
E-Mail dimitrirenard@hotmail.com


 goto top of outline Article Information

Published online: March 7, 2008
Number of Print Pages : 2


 goto top of outline Publication Details

Cerebrovascular Diseases

Vol. 25, No. 3, Year 2008 (Cover Date: March 2008)

Journal Editor: Hennerici M.G. (Mannheim)
ISSN: 1015–9770 (Print), eISSN: 1421–9786 (Online)

For additional information: http://www.karger.com/CED


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.